Abstract

Polymorphisms and mutations in the surfactant protein B (SP-B) gene have been associated with the pathogenesis of respiratory distress syndrome (RDS). The objective of the present study was to compare the frequencies of SP-B gene polymorphisms between preterm babies with RDS and healthy term newborns. We studied 50 preterm babies with RDS (inclusion criteria - newborns with RDS and gestational age between 28 and 33 weeks and 6 days), and 100 healthy term newborns. Four SP-B gene polymorphisms were analyzed: A/C at nucleotide -18, C/T at nucleotide 1580, A/G at nucleotide 9306, and G/C at nucleotide 8714, by PCR amplification of genomic DNA and genotyping by cRFLP. The healthy newborns comprised 42 female and 58 male neonates; 39 were white and 61 non-white. The RDS group comprised 21 female and 29 male preterm neonates; 28 were white and 22 non-white. Weight ranged from 640 to 2080 g (mean: 1273 g); mean gestational age was 31 weeks and 2 days (range: 28-33 weeks and 6 days). When white children were analyzed separately, a statistically significant difference in the G/C polymorphism at 8714 was observed between groups (P = 0.028). All other genotype frequencies were similar for both groups when sex and race were analyzed together. Analysis of the SP-B polymorphism G/C at nucleotide 8714 showed that among white neonates the GG genotype was found only in the RDS group at a frequency of 17% and the GC genotype was more frequently found in healthy term newborns. These data demonstrate an association of GG genotype with RDS.

Highlights

  • Pulmonary surfactant is a lipid-protein complex essential for normal lung function, responsible for reducing the superficial tension of the air-liquid interface of the alveoli, preventing lung collapse at the end of expiration [1]

  • Four proteins are associated with the surfactant complex: SP-A, surfactant protein B (SP-B), SP-C, and SP-D, playing important roles in surfactant function and metabolism [3]

  • We studied 150 neonates who were classified in two groups: healthy term newborns and respiratory distress syndrome (RDS) preterm newborns

Read more

Summary

Introduction

Pulmonary surfactant is a lipid-protein complex essential for normal lung function, responsible for reducing the superficial tension of the air-liquid interface of the alveoli, preventing lung collapse at the end of expiration [1]. Avery and Mead [1] showed in 1959 that pulmonary surfactant deficiency is a major factor in the pathophysiology of respiratory distress syndrome (RDS). Surfactant is a mixture of lipids (~90%) and proteins (~10%). Phospholipids represent 80-90% of the surfactant lipids, of which phosphatidylcholine is the most important, accounting for 70-80% of the total. Dipalmitoylphosphatidylcholine represents about 60% and is the principal surface tensionlowering component of surfactant [2]. Four proteins are associated with the surfactant complex: SP-A, SP-B, SP-C, and SP-D, playing important roles in surfactant function and metabolism [3]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call